| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5842289 | Life Sciences | 2013 | 6 Pages |
Abstract
The data suggest that COX-1contributes to vasoconstrictor effects in WKY kidneys and that COX-2 has the same effect in SHR kidneys. The results also suggest that basal release of COX-2-derived vasoconstrictor prostanoids is involved in renal vascular hypersensitivity in SHR.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Estela D'Abril RuÃz-Leyja, Rafael Villalobos-Molina, Juan Javier López-Guerrero, Itzell Alejandrina Gallardo-OrtÃz, Samuel Enoch Estrada-Soto, Maximiliano Ibarra-Barajas,